Stockreport

Cortexyme Announces $125 Million Private Placement

Cortexyme, Inc.  (CRTX) 
PDF SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therape [Read more]